Paradoxical E-cadherin increase in 5FU-resistant colon cancer is unaffected during mesenchymal–epithelial reversion induced by γ-secretase inhibition
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 145, 174-183
Abstract
No abstract availableKeywords
Funding Information
- King Saud University (RG#164)
This publication has 48 references indexed in Scilit:
- Metastatic Progression of Prostate Cancer and E-CadherinThe American Journal of Pathology, 2011
- Notch signaling as a therapeutic target for breast cancer treatment?Breast Cancer Research, 2011
- Inflammation and EMT: an alliance towards organ fibrosis and cancer progressionEMBO Molecular Medicine, 2009
- EMT: When epithelial cells decide to become mesenchymal-like cellsJournal of Clinical Investigation, 2009
- Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor InhibitionCancer Research, 2009
- γ-Secretase Inhibitors Abrogate Oxaliplatin-Induced Activation of the Notch-1 Signaling Pathway in Colon Cancer Cells Resulting in Enhanced ChemosensitivityCancer Research, 2009
- Snail and Slug Promote Epithelial-Mesenchymal Transition through β-Catenin–T-Cell Factor-4-dependent Expression of Transforming Growth Factor-β3Molecular Biology of the Cell, 2008
- A Role for the Cleaved Cytoplasmic Domain of E-cadherin in the NucleusJournal of Biological Chemistry, 2008
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature Cell Biology, 2000
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970